{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:12:55Z","timestamp":1787170375340,"version":"build-2736575974"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s40266-021-00917-8","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T22:04:33Z","timestamp":1643666673000},"page":"191-198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Onychomycosis in Older Adults: Prevalence, Diagnosis, and Management"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8664-7723","authenticated-orcid":false,"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maanasa","family":"Venkataraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesbah","family":"Talukder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"issue":"6","key":"917_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2165\/00002512-200016060-00002","volume":"16","author":"AK Gupta","year":"2000","unstructured":"Gupta AK. Onychomycosis in the elderly. Drugs Aging. 2000;16(6):397\u2013407.","journal-title":"Drugs Aging"},{"issue":"9","key":"917_CR2","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1111\/jdv.16394","volume":"34","author":"AK Gupta","year":"2020","unstructured":"Gupta AK, Stec N, Summerbell RC, Shear NH, Piguet V, Tosti A, et al. Onychomycosis: a review. J Eur Acad Dermatol Venereol. 2020;34(9):1972\u201390.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"917_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/00128071-200001010-00002","volume":"1","author":"BE Elewski","year":"2000","unstructured":"Elewski BE. Onychomycosis. Am J Clin Dermatol. 2000;1(1):19\u201326.","journal-title":"Am J Clin Dermatol"},{"issue":"10","key":"917_CR4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1046\/j.1365-4362.1997.00349.x","volume":"36","author":"AK Gupta","year":"1997","unstructured":"Gupta AK, Jain HC, Lynde CW, Watteel GN, Summerbell RC. Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists\u2019 offices in Ontario, Canada-a multicenter survey of 2001 patients. Int J Dermatol. 1997;36(10):783\u20137.","journal-title":"Int J Dermatol"},{"issue":"4","key":"917_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0190-9622(92)70075-Q","volume":"26","author":"PR Cohen","year":"1992","unstructured":"Cohen PR, Scher RK. Geriatric nail disorders: diagnosis and treatment. J Am Acad Dermatol. 1992;26(4):521\u201331.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"917_CR6","first-page":"173","volume":"57","author":"L Abdullah","year":"2011","unstructured":"Abdullah L, Abbas O. Common nail changes and disorders in older people: diagnosis and management. Can Fam Physician. 2011;57(2):173\u201381.","journal-title":"Can Fam Physician"},{"issue":"9","key":"917_CR7","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1111\/jdv.13677","volume":"30","author":"A Gupta","year":"2016","unstructured":"Gupta A, Gupta G, Jain H, Lynde C, Foley K, Daigle D, et al. The prevalence of unsuspected onychomycosis and its causative organisms in a multicentre Canadian sample of 30 000 patients visiting physicians\u2019 offices. J Eur Acad Dermatol Venereol. 2016;30(9):1567\u201372.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"917_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2165\/00002512-200724040-00003","volume":"24","author":"DS Loo","year":"2007","unstructured":"Loo DS. Onychomycosis in the elderly. Drugs Aging. 2007;24(4):293\u2013302.","journal-title":"Drugs Aging"},{"issue":"5","key":"917_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1365-2710.2009.01107.x","volume":"35","author":"J Thomas","year":"2010","unstructured":"Thomas J, Jacobson G, Narkowicz C, Peterson G, Burnet H, Sharpe C. Toenail onychomycosis: an important global disease burden. J Clin Pharm Ther. 2010;35(5):497\u2013519.","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"917_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1067\/mjd.2000.104794","volume":"43","author":"AK Gupta","year":"2000","unstructured":"Gupta AK, Jain HC, Lynde CW, MacDonald P, Cooper EA, Summerbell RC. Prevalence and epidemiology of onychomycosis in patients visiting physicians\u2019 offices: a multicenter Canadian survey of 15,000 patients. J Am Acad Dermatol. 2000;43(2):244\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"917_CR11","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3390\/pathogens9100851","volume":"9","author":"H Sakkas","year":"2020","unstructured":"Sakkas H, Kittas C, Kapnisi G, Priavali E, Kallinteri A, Bassukas ID, et al. Onychomycosis in Northwestern Greece over a 7-year period. Pathogens. 2020;9(10):851.","journal-title":"Pathogens"},{"issue":"3","key":"917_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000051640","volume":"202","author":"G Pi\u00e9rard","year":"2001","unstructured":"Pi\u00e9rard G. Onychomycosis and other superficial fungal infections of the foot in the elderly: a pan-European survey. Dermatology. 2001;202(3):220\u20134.","journal-title":"Dermatology"},{"issue":"6","key":"917_CR13","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1365-4632.2005.02607.x","volume":"45","author":"B Yal\u00e7\u0131n","year":"2006","unstructured":"Yal\u00e7\u0131n B, Tamer E, Toy GG, \u00d6zta\u015f P, Hayran M, All\u0131 N. The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients. Int J Dermatol. 2006;45(6):672\u20136.","journal-title":"Int J Dermatol"},{"issue":"11","key":"917_CR14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s11046-016-0040-5","volume":"181","author":"A Shemer","year":"2016","unstructured":"Shemer A, Gupta AK, Amichai B, Baum S, Barzilai A, Farhi R, et al. Increased risk of tinea pedis and onychomycosis among swimming pool employees in Netanya area, Israel. Mycopathologia. 2016;181(11):851\u20136.","journal-title":"Mycopathologia"},{"issue":"10","key":"917_CR15","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/archderm.142.10.1279","volume":"142","author":"JC Szepietowski","year":"2006","unstructured":"Szepietowski JC, Reich A, Garlowska E, Kulig M, Baran E. Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses: a survey of 2761 patients. Arch Dermatol. 2006;142(10):1279\u201384.","journal-title":"Arch Dermatol"},{"issue":"5","key":"917_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1177\/1203475415581310","volume":"19","author":"AK Gupta","year":"2015","unstructured":"Gupta AK, Sibbald RG, Andriessen A, Belley R, Boroditsky A, Botros M, et al. Toenail onychomycosis\u2014a Canadian approach with a new transungual treatment: development of a clinical pathway. J Cutan Med Surg. 2015;19(5):440\u20139.","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"917_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.7547\/17-070","volume":"109","author":"A Joyce","year":"2019","unstructured":"Joyce A, Gupta AK, Koenig L, Wolcott R, Carviel J. Fungal diversity and onychomycosis: an analysis of 8,816 toenail samples using quantitative PCR and next-generation sequencing. J Am Podiatr Med Assoc. 2019;109(1):57\u201363.","journal-title":"J Am Podiatr Med Assoc"},{"issue":"9","key":"917_CR18","doi-asserted-by":"publisher","first-page":"e0239648","DOI":"10.1371\/journal.pone.0239648","volume":"15","author":"AK Gupta","year":"2020","unstructured":"Gupta AK, Taborda VB, Taborda PR, Shemer A, Summerbell RC, Nakrieko K-A. High prevalence of mixed infections in global onychomycosis. PLoS ONE. 2020;15(9):e0239648.","journal-title":"PLoS ONE"},{"key":"917_CR19","doi-asserted-by":"crossref","unstructured":"Pi\u00e9rard GE, Arrese JE, Pi\u00e9rard-Franchimont C, Quatresooz P. Onychomycosis in older patients. Aging Health. 2006;2(5).","DOI":"10.2217\/1745509X.2.5.865"},{"key":"917_CR20","doi-asserted-by":"crossref","unstructured":"Gupta AK, Talukder M. Efinaconazole in onychomycosis. Am J Clin Dermatol. 2021.","DOI":"10.1007\/s40257-021-00660-1"},{"issue":"5","key":"917_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4155\/tde-2016-0090","volume":"8","author":"AK Tiwary","year":"2017","unstructured":"Tiwary AK, Sapra B. High failure rate of transungal drug delivery: need for new strategies. Ther Deliv. 2017;8(5):239\u201342.","journal-title":"Ther Deliv"},{"issue":"3","key":"917_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/09546634.2019.1654598","volume":"32","author":"A Shemer","year":"2021","unstructured":"Shemer A, Gupta AK, Kamshov S, Babaev M, Hermush V, Farhi R, et al. Continuous terbinafine and pulse itraconazole for the treatment of non-dermatophyte mold toenail onychomycosis. J Dermatolog Treat. 2021;32(3):310\u20133.","journal-title":"J Dermatolog Treat"},{"issue":"10","key":"917_CR23","first-page":"s93","volume":"20","author":"SR Lipner","year":"2021","unstructured":"Lipner SR, Joseph WS, Vlahovic TC, Scher RK, Rich P, Ghannoum M, et al. Therapeutic recommendations for the treatment of toenail onychomycosis in the US. J Drugs Dermatol. 2021;20(10):s93.","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"917_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/1346-8138.15651","volume":"48","author":"H Noguchi","year":"2021","unstructured":"Noguchi H, Matsumoto T, Kimura U, Hiruma M, Kano R, Kubo M, et al. Fosravuconazole to treat severe onychomycosis in the elderly. J Dermatol. 2021;48(2):228\u201331.","journal-title":"J Dermatol"},{"issue":"1","key":"917_CR25","first-page":"5","volume":"26","author":"AK Gupta","year":"2021","unstructured":"Gupta AK, Cooper EA. Long-term efficacy and safety of once-daily efinaconazole 10% topical solution (Jublia) for dermatophyte toenail onychomycosis: an interim analysis. Skin Ther Lett. 2021;26(1):5\u201310.","journal-title":"Skin Ther Lett"},{"issue":"8","key":"917_CR26","first-page":"633","volume":"9","author":"AK Gupta","year":"1999","unstructured":"Gupta AK, Konnikov N, Lynde C, Summerbell R, Albreski D, Baran R, et al. Onychomycosis: predisposed populations and some predictors of suboptimal response to oral antifungal agents. Eur J Dermatol. 1999;9(8):633\u20138.","journal-title":"Eur J Dermatol"},{"issue":"1","key":"917_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.hgmx.2015.10.004","volume":"79","author":"J Araiza-Santib\u00e1nez","year":"2016","unstructured":"Araiza-Santib\u00e1nez J, Tirado-Sanchez A, Gonzalez-Rodriguez A, Vazquez-Escorcia L, Ponce-Olivera R, Bonifaz A. Onychomycosis in the elderly. A 2-year retrospective study of 138 cases. Rev M\u00e9d del Hosp Gen de M\u00e9xico. 2016;79(1):5\u201310.","journal-title":"Rev M\u00e9d del Hosp Gen de M\u00e9xico"},{"issue":"3","key":"917_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/CDR.CDR_32_17","volume":"1","author":"R Shivanna","year":"2017","unstructured":"Shivanna R. Management of dermatophytosis in elderly and with systemic comorbidities. Clin Dermatol Rev. 2017;1(3):38.","journal-title":"Clin Dermatol Rev"},{"issue":"4","key":"917_CR29","first-page":"299","volume":"1","author":"B Elewski","year":"2005","unstructured":"Elewski B, Tavakkol A. Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality. Ther Clin Risk Manag. 2005;1(4):299.","journal-title":"Ther Clin Risk Manag"},{"key":"917_CR30","first-page":"419","volume":"120","author":"RJ Glassock","year":"2009","unstructured":"Glassock RJ, Winearls C. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc. 2009;120:419.","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"4","key":"917_CR31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1046\/j.1365-2133.1998.02464.x","volume":"139","author":"AK Gupta","year":"1998","unstructured":"Gupta AK, Konnikov N, MacDonald P, Rich P, Rodger N, Edmonds M, et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol. 1998;139(4):665\u201371.","journal-title":"Br J Dermatol"},{"issue":"5","key":"917_CR32","first-page":"379","volume":"10","author":"AK Gupta","year":"2000","unstructured":"Gupta AK, Humke S. The prevalence and management of onychomycosis in diabetic patients. Eur J Dermatol. 2000;10(5):379\u201384.","journal-title":"Eur J Dermatol"},{"issue":"2","key":"917_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2165\/00002512-200421020-00003","volume":"21","author":"JS Tan","year":"2004","unstructured":"Tan JS, Joseph WS. Common fungal infections of the feet in patients with diabetes mellitus. Drugs Aging. 2004;21(2):101\u201312.","journal-title":"Drugs Aging"},{"issue":"3\u20134","key":"917_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1046\/j.1439-0507.2001.00624.x","volume":"44","author":"C Romano","year":"2001","unstructured":"Romano C, Massai L, Asta F, Signorini A. Prevalence of dermatophytic skin and nail infections in diabetic patients. Mycoses. 2001;44(3\u20134):83\u20136.","journal-title":"Mycoses"},{"issue":"10","key":"917_CR35","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1046\/j.1365-4362.2002.01528.x","volume":"41","author":"S Dogra","year":"2002","unstructured":"Dogra S, Kumar B, Bhansali A, Chakrabarty A. Epidemiology of onychomycosis in patients with diabetes mellitus in India. Int J Dermatol. 2002;41(10):647\u201351.","journal-title":"Int J Dermatol"},{"issue":"8","key":"917_CR36","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/j.1365-2230.2008.03174.x","volume":"34","author":"A Sadighha","year":"2009","unstructured":"Sadighha A, Mohagheghzahed G. Onychomycosis: report on experience with itraconazole in 37 patients aged older than 50 years: a multivariate regression. Clin Exp Dermatol. 2009;34(8):924\u20135.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"917_CR37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1468-3083.2009.03476.x","volume":"24","author":"A Salem","year":"2010","unstructured":"Salem A, Gamil H, Hamed M, Galal S. Nail changes in patients with liver disease. J Eur Acad Dermatol Venereol. 2010;24(6):649\u201354.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"917_CR38","unstructured":"Highlights of prescribing information, LAMISIL (terbinafine hydrochloride) tablets, for oral use (FDA label). 2019. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/020539s033lbl.pdf. Cited 6 Aug 2021"},{"key":"917_CR39","unstructured":"SPORANOX\u00ae(itraconazole) capsules (FDA label) 2019. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/020083s063lbl.pdf. Cited 6 Aug 2021"},{"issue":"2","key":"917_CR40","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1046\/j.1365-2133.2001.04062.x","volume":"144","author":"J Tercedor","year":"2001","unstructured":"Tercedor J, L\u00f3pez Hern\u00e1ndez B, R\u00f3denas JM. Nail diseases in haemodialysis patients: case\u2013control study. Br J Dermatol. 2001;144(2):445\u20136.","journal-title":"Br J Dermatol"},{"issue":"1","key":"917_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-7-102","volume":"7","author":"G Kuvandik","year":"2007","unstructured":"Kuvandik G, \u00c7etin M, Genctoy G, Horoz M, Duru M, Akcali C, et al. The prevalance, epidemiology and risk factors for onychomycosis in hemodialysis patients. BMC Infect Dis. 2007;7(1):1\u20135.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"917_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/myc.12114","volume":"57","author":"M Irimie","year":"2014","unstructured":"Irimie M, T\u0103taru A, Oant\u0103 A, Moga M. In vitro susceptibility of dermatophytes isolated from patients with end-stage renal disease: a case\u2013control study. Mycoses. 2014;57(3):129\u201334.","journal-title":"Mycoses"},{"issue":"6","key":"917_CR43","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1046\/j.1468-3083.2000.00124.x","volume":"14","author":"AK Gupta","year":"2000","unstructured":"Gupta AK, Gupta MA, Summerbell RC, Cooper EA, Konnikov N, Albreski D, et al. The epidemiology of onychomycosis: possible role of smoking and peripheral arterial disease. J Eur Acad Dermatol Venereol. 2000;14(6):466\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"917_CR44","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1001\/archderm.1997.03890460029004","volume":"133","author":"M Hall","year":"1997","unstructured":"Hall M, Monka C, Krupp P, O\u2019Sullivan D. Safety of oral terbinafine: results of a postmarketing surveillance study in 25 884 patients. Arch Dermatol. 1997;133(10):1213\u20139.","journal-title":"Arch Dermatol"},{"issue":"4","key":"917_CR45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000514361","volume":"7","author":"AK Gupta","year":"2021","unstructured":"Gupta AK, Venkataraman M, Renaud HJ, Summerbell R, Shear NH, Piguet V. A paradigm shift in the treatment and management of onychomycosis. Skin Appendage Disorders. 2021;7(4):251\u20138.","journal-title":"Skin Appendage Disorders"},{"key":"917_CR46","unstructured":"Intriago J. Elderly nail fungus: prevention and early treatment. 2021; https:\/\/www.seniorsmatter.com\/treating-preventing-nail-fungus-elderly\/2491913\/. Cited 02 Sept 2021"},{"issue":"3","key":"917_CR47","first-page":"279","volume":"15","author":"AK Gupta","year":"2016","unstructured":"Gupta AK, Elewski BE, Rosen T, Caldwell B, Pariser DM, Kircik LH, et al. Onychomycosis: strategies to minimize recurrence. J Drugs Dermatol. 2016;15(3):279\u201382.","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"917_CR48","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2310\/7750.2013.12088","volume":"17","author":"AK Gupta","year":"2013","unstructured":"Gupta AK, Cooper EA, Paquet M. Recurrences of dermatophyte toenail onychomycosis during long-term follow-up after successful treatments with mono-and combined therapy of terbinafine and itraconazole. J Cutan Med Surg. 2013;17(3):201\u20136.","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"917_CR49","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000017990","volume":"197","author":"A Tosti","year":"1998","unstructured":"Tosti A, Piraccini B, Stinchi C, Colombo M. Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up. Dermatology. 1998;197(2):162\u20136.","journal-title":"Dermatology"},{"issue":"3","key":"917_CR50","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1001\/archderm.138.3.353","volume":"138","author":"B Sigurgeirsson","year":"2002","unstructured":"Sigurgeirsson B, \u00d3lafsson JH, Steinsson J, Paul C, Billstein S, Evans EGV. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study. Arch Dermatol. 2002;138(3):353\u20137.","journal-title":"Arch Dermatol"},{"issue":"2","key":"917_CR51","doi-asserted-by":"publisher","first-page":"141","DOI":"10.7547\/17-043","volume":"109","author":"AK Gupta","year":"2019","unstructured":"Gupta AK, Versteeg SG. The role of shoe and sock sanitization in the management of superficial fungal infections of the feet. J Am Podiatr Med Assoc. 2019;109(2):141\u20139.","journal-title":"J Am Podiatr Med Assoc"},{"issue":"3","key":"917_CR52","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.foot.2008.03.005","volume":"18","author":"RC Zatcoff","year":"2008","unstructured":"Zatcoff RC, Smith MS, Borkow G. Treatment of tinea pedis with socks containing copper-oxide impregnated fibers. Foot. 2008;18(3):136\u201341.","journal-title":"Foot"},{"issue":"4","key":"917_CR53","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2310\/7750.2012.12068","volume":"17","author":"AK Gupta","year":"2013","unstructured":"Gupta AK, Brintnell WC. Sanitization of contaminated footwear from onychomycosis patients using ozone gas: a novel adjunct therapy for treating onychomycosis and tinea pedis? J Cutan Med Surg. 2013;17(4):243\u20139.","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"917_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11046-010-9347-9","volume":"171","author":"TR Hammer","year":"2011","unstructured":"Hammer TR, Mucha H, Hoefer D. Infection risk by dermatophytes during storage and after domestic laundry and their temperature-dependent inactivation. Mycopathologia. 2011;171(1):43\u20139.","journal-title":"Mycopathologia"},{"issue":"11","key":"917_CR55","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1111\/ijd.12167","volume":"52","author":"B Amichai","year":"2013","unstructured":"Amichai B, Grunwald MH, Davidovici B, Farhi R, Shemer A. The effect of domestic laundry processes on fungal contamination of socks. Int J Dermatol. 2013;52(11):1392\u20134.","journal-title":"Int J Dermatol"},{"issue":"4","key":"917_CR56","doi-asserted-by":"publisher","first-page":"309","DOI":"10.7547\/1020309","volume":"102","author":"MA Ghannoum","year":"2012","unstructured":"Ghannoum MA, Isham N, Long L. Optimization of an infected shoe model for the evaluation of an ultraviolet shoe sanitizer device. J Am Podiatr Med Assoc. 2012;102(4):309\u201313.","journal-title":"J Am Podiatr Med Assoc"},{"issue":"7","key":"917_CR57","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1365-2133.1955.tb12730.x","volume":"67","author":"R Beoughton","year":"1955","unstructured":"Beoughton R. Reinfection from socks and shoes in tinea pedis. Br J Dermatol. 1955;67(7):249\u201354.","journal-title":"Br J Dermatol"},{"issue":"4","key":"917_CR58","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1139\/w05-130","volume":"52","author":"K Ara","year":"2006","unstructured":"Ara K, Hama M, Akiba S, Koike K, Okisaka K, Hagura T, et al. Foot odor due to microbial metabolism and its control. Can J Microbiol. 2006;52(4):357\u201364.","journal-title":"Can J Microbiol"},{"issue":"11","key":"917_CR59","first-page":"1097","volume":"14","author":"HA Dixon","year":"1924","unstructured":"Dixon HA. The study of fungi in diseases of the skin. Can Med Assoc J. 1924;14(11):1097.","journal-title":"Can Med Assoc J"},{"issue":"4","key":"917_CR60","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1439-0507.2011.02121.x","volume":"55","author":"TR Hammer","year":"2012","unstructured":"Hammer TR, Mucha H, Hoefer D. Dermatophyte susceptibility varies towards antimicrobial textiles. Mycoses. 2012;55(4):344\u201351.","journal-title":"Mycoses"},{"issue":"6","key":"917_CR61","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1111\/jam.12647","volume":"117","author":"M Honisch","year":"2014","unstructured":"Honisch M, Stamminger R, Bockm\u00fchl DP. Impact of wash cycle time, temperature and detergent formulation on the hygiene effectiveness of domestic laundering. J Appl Microbiol. 2014;117(6):1787\u201397.","journal-title":"J Appl Microbiol"},{"issue":"2","key":"917_CR62","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2174\/2212796809666150227223857","volume":"8","author":"G Borkow","year":"2014","unstructured":"Borkow G. Using copper to improve the well-being of the skin. Curr Chem Biol. 2014;8(2):89\u2013102.","journal-title":"Curr Chem Biol"},{"issue":"116","key":"917_CR63","first-page":"2","volume":"3","author":"G Borkow","year":"2017","unstructured":"Borkow G, Kanmukhla V, Monk A. Improvement to foot and skin appearance by using copper oxide impregnated socks-a report of a large scale internet based user survey. J Cosmo Trichol. 2017;3(116):2.","journal-title":"J Cosmo Trichol."},{"key":"917_CR64","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.bjm.2016.04.014","volume":"47","author":"SA Ouf","year":"2016","unstructured":"Ouf SA, Moussa TA, Abd-Elmegeed AM, Eltahlawy SR. Anti-fungal potential of ozone against some dermatophytes. Braz J Microbiol. 2016;47:697\u2013702.","journal-title":"Braz J Microbiol"},{"issue":"3","key":"917_CR65","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/09546634.2012.714456","volume":"25","author":"AK Gupta","year":"2014","unstructured":"Gupta AK, Brintnell W. Ozone gas effectively kills laboratory strains of Trichophyton rubrum and Trichophyton mentagrophytes using an in vitro test system. J Dermatolog Treat. 2014;25(3):251\u20135.","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"917_CR66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/003335491012500105","volume":"125","author":"NG Reed","year":"2010","unstructured":"Reed NG. The history of ultraviolet germicidal irradiation for air disinfection. Public Health Rep. 2010;125(1):15\u201327.","journal-title":"Public Health Rep"},{"issue":"3","key":"917_CR67","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0255-0857(21)01870-3","volume":"26","author":"G Katara","year":"2008","unstructured":"Katara G, Hemvani N, Chitnis S, Chitnis V, Chitnis D. Surface disinfection by exposure to germicidal UV light. Indian J Med Microbiol. 2008;26(3):241\u20132.","journal-title":"Indian J Med Microbiol"},{"issue":"6","key":"917_CR68","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1365-2133.2008.08549.x","volume":"158","author":"T Dai","year":"2008","unstructured":"Dai T, Tegos G, Rolz-Cruz G, Cumbie W, Hamblin M. Ultraviolet C inactivation of dermatophytes: implications for treatment of onychomycosis. Br J Dermatol. 2008;158(6):1239\u201346.","journal-title":"Br J Dermatol"},{"key":"917_CR69","doi-asserted-by":"crossref","unstructured":"Nematollahi AR, Badiee P, Nournia E. The efficacy of ultraviolet irradiation on Trichophyton species isolated from nails. Jundishapur J Microbiol 2015;8(6).","DOI":"10.5812\/jjm.18158v2"},{"issue":"2","key":"917_CR70","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1586\/eri.11.166","volume":"10","author":"T Dai","year":"2012","unstructured":"Dai T, Vrahas MS, Murray CK, Hamblin MR. Ultraviolet C irradiation: an alternative antimicrobial approach to localized infections? Expert Rev Anti Infect Ther. 2012;10(2):185\u201395.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"4","key":"917_CR71","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/myc.12144","volume":"57","author":"D Budihardja","year":"2014","unstructured":"Budihardja D, Mayser P. The effect of microwave irradiation on the vitality of various dermatophytes. Mycoses. 2014;57(4):209\u201313.","journal-title":"Mycoses"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-021-00917-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-021-00917-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-021-00917-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T00:30:31Z","timestamp":1666485031000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-021-00917-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["917"],"URL":"https:\/\/doi.org\/10.1007\/s40266-021-00917-8","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"16 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"AKG, MV, and MT have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Conception of the manuscript: AKG. The work was drafted by MV and MT and substantively revised by AKG, MV, and MT.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}